# ZF2001 Booster Immunization Clinical Trials of 6 Months After the Completion of Basic Immunization

> **NCT05198063** · PHASE1,PHASE2 · COMPLETED · sponsor: **Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.** · enrollment: 300 (actual)

## Conditions studied

- Prevention of COVID-19

## Interventions

- **BIOLOGICAL:** Recombinant novel coronavirus vaccine (CHO cells)

## Key facts

- **NCT ID:** NCT05198063
- **Lead sponsor:** Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-10
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-12-06
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2023-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05198063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05198063, "ZF2001 Booster Immunization Clinical Trials of 6 Months After the Completion of Basic Immunization". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05198063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*